August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study – Multiple Myeloma Hub
Jun 20, 2024, 11:53

Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study – Multiple Myeloma Hub

Multiple Myeloma Hub shared on X/Twitter:

CONGRESS | POSTER | EHA2024 | Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study of elranatamab in patients with RRMM, N=123. ORR remained at 61%, with median DoR not reached.”

Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study - Multiple Myeloma Hub

Source: Multiple Myeloma Hub/X